Article
PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation.
British journal of haematology - 1 Feb 2008
Tibes Raoul, Kornblau Steven M, Qiu Yihua, Mousses Spyro M, Robbins Christiane, Moses Tracy, Carpten John D
Abstract excerpt
Despite its' central role, the precise mechanisms of the phosphoinositide 3-kinase/Akt (PI3K)/Akt pathway activation in acute myeloid leukaemia (AML) have not been elucidated. Recently, a recurrent novel AKT1 pleckstrin homology domain (PHD) mutation leading to membrane translocation, constitutive AKT activation and leukaemia development in mice was described. To assess AKT1 PHD mutations in AML, we sequenced 57...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
